• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病作为帕金森病的一个危险因素:分子观点。

Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.

机构信息

Molecular Physiology and Biophysics Unit, Department of Biology, University of Padova, Padova, Italy.

Department of Experimental Neurodegeneration, University Medical Center Goettingen, Goettingen, Germany.

出版信息

Mol Neurobiol. 2018 Nov;55(11):8754-8763. doi: 10.1007/s12035-018-1025-9. Epub 2018 Mar 28.

DOI:10.1007/s12035-018-1025-9
PMID:29594935
Abstract

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by elevated concentrations of glucose in the blood. The chronic hyperglycemic state accounts for most of the vascular complications associated to the disease and the prevalent mechanism proposed is related to the glycating chemistry mediated by methylglyoxal (MG), which accumulates in T2DM. In recent years, a higher risk of Parkinson's disease (PD) onset in people affected by T2DM has become evident, but the molecular mechanisms underlying the interplay between T2DM and PD are still unknown. The oxidative chemistry of dopamine and its reactivity towards the protein α-Synuclein (aS) has been associated to the pathogenesis of PD. Recently, aS has also been described to interact with MG. Interestingly, MG and the dopamine oxidation products share both structural similarity and chemical reactivity. The ability of MG to spread over the site of its production and react with aS could represent the rationale to explain the higher incidence of PD in T2DM-affected people and may open opportunities for the development of novel strategies to antagonize the raise of PD.

摘要

2 型糖尿病(T2DM)是一种代谢紊乱,其特征是血液中葡萄糖浓度升高。慢性高血糖状态是与该疾病相关的大多数血管并发症的主要原因,而目前流行的机制与甲基乙二醛(MG)介导的糖化化学有关,MG 在 T2DM 中积累。近年来,人们明显发现 2 型糖尿病患者患帕金森病(PD)的风险更高,但 T2DM 和 PD 之间相互作用的分子机制仍不清楚。多巴胺的氧化化学及其与蛋白质α-突触核蛋白(aS)的反应性与 PD 的发病机制有关。最近,aS 也被描述为与 MG 相互作用。有趣的是,MG 和多巴胺氧化产物既有结构相似性又有化学反应性。MG 扩散到其产生部位并与 aS 反应的能力可以解释 T2DM 患者 PD 发病率较高的原因,并可能为开发新的策略来拮抗 PD 的发生提供机会。

相似文献

1
Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.糖尿病作为帕金森病的一个危险因素:分子观点。
Mol Neurobiol. 2018 Nov;55(11):8754-8763. doi: 10.1007/s12035-018-1025-9. Epub 2018 Mar 28.
2
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms.糖尿病与帕金森病:共同分子机制的认识。
J Parkinsons Dis. 2024;14(5):917-924. doi: 10.3233/JPD-230104.
3
A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.一种新发现的与高血糖和帕金森病相关的神经毒素ADTIQ。
Biochem Biophys Res Commun. 2015 Apr 10;459(3):361-6. doi: 10.1016/j.bbrc.2015.02.069. Epub 2015 Mar 3.
4
Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.2 型糖尿病与帕金森病的趋同分子途径:对发病机制和病理后果的深入了解。
Mol Neurobiol. 2022 Jul;59(7):4466-4487. doi: 10.1007/s12035-022-02867-7. Epub 2022 May 16.
5
Unveiling new secrets in Parkinson's disease: The glycatome.揭示帕金森病的新秘密:糖基组。
Behav Brain Res. 2023 Mar 28;442:114309. doi: 10.1016/j.bbr.2023.114309. Epub 2023 Jan 24.
6
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?帕金森病与α-突触核蛋白:帕金森病是否为类朊病毒疾病?
Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373.
7
Common pathophysiology affecting diabetic retinopathy and Parkinson's disease.影响糖尿病视网膜病变和帕金森病的常见病理生理学。
Med Hypotheses. 2015 Oct;85(4):397-8. doi: 10.1016/j.mehy.2015.06.016. Epub 2015 Jun 26.
8
System-based approaches to decode the molecular links in Parkinson's disease and diabetes.基于系统的方法来解码帕金森病和糖尿病中的分子联系。
Neurobiol Dis. 2014 Dec;72 Pt A:84-91. doi: 10.1016/j.nbd.2014.03.019. Epub 2014 Apr 6.
9
Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?突触核蛋白、多巴胺与氧化应激:帕金森病中的共谋者?
Brain Res Mol Brain Res. 2005 Mar 24;134(1):18-23. doi: 10.1016/j.molbrainres.2004.09.014.
10
Alpha-synuclein and Parkinson's disease: a proteomic view.α-突触核蛋白与帕金森病:蛋白质组学视角
Expert Rev Proteomics. 2008 Apr;5(2):239-48. doi: 10.1586/14789450.5.2.239.

引用本文的文献

1
Human Glucose Transporters in Health and Selected Neurodegenerative Diseases.健康与特定神经退行性疾病中的人类葡萄糖转运蛋白
Int J Mol Sci. 2025 Jul 31;26(15):7392. doi: 10.3390/ijms26157392.
2
Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence.合并症及其对帕金森病的影响:当前证据的叙述性概述
Int J Mol Sci. 2025 Mar 24;26(7):2942. doi: 10.3390/ijms26072942.
3
Neuroprotective effects of semaglutide and metformin against rotenone-induced neurobehavioral changes in male diabetic rats.

本文引用的文献

1
Gestational diabetes from A to Z.妊娠期糖尿病全解。
World J Diabetes. 2017 Dec 15;8(12):489-511. doi: 10.4239/wjd.v8.i12.489.
2
Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease.2型糖尿病在阿尔茨海默病的病理生理学中。
Dement Neuropsychol. 2017 Apr-Jun;11(2):105-113. doi: 10.1590/1980-57642016dn11-020002.
3
Impaired peripheral glucose homeostasis and Alzheimer's disease.外周葡萄糖稳态受损与阿尔茨海默病。
司美格鲁肽和二甲双胍对鱼藤酮诱导的雄性糖尿病大鼠神经行为变化的神经保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 15. doi: 10.1007/s00210-025-03920-7.
4
The Interplay of Stress, Inflammation, and Metabolic Factors in the Course of Parkinson's Disease.应激、炎症和代谢因素在帕金森病病程中的相互作用。
Int J Mol Sci. 2024 Nov 19;25(22):12409. doi: 10.3390/ijms252212409.
5
Resveratrol protects pancreatic beta cell and hippocampal cells from the aggregate-prone capacity of hIAPP.白藜芦醇可保护胰岛β细胞和海马细胞免受 hIAPP 聚集的影响。
Sci Rep. 2024 Nov 11;14(1):27523. doi: 10.1038/s41598-024-78967-2.
6
Genetic insights into the connection between pulmonary TB and non-communicable diseases: An integrated analysis of shared genes and potential treatment targets.遗传视角下的肺结核与非传染性疾病的关联:共享基因与潜在治疗靶点的综合分析。
PLoS One. 2024 Oct 21;19(10):e0312072. doi: 10.1371/journal.pone.0312072. eCollection 2024.
7
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis.司美格鲁肽通过肠道菌群-肠-脑轴减轻 2 型糖尿病小鼠的焦虑和抑郁样行为并逆转认知障碍。
J Neuroimmune Pharmacol. 2024 Jul 23;19(1):36. doi: 10.1007/s11481-024-10142-w.
8
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms.糖尿病与帕金森病:共同分子机制的认识。
J Parkinsons Dis. 2024;14(5):917-924. doi: 10.3233/JPD-230104.
9
Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.揭示关联:2型糖尿病与帕金森病——一种基于纳米的靶向药物递送方法
Curr Diabetes Rev. 2025;21(6):32-58. doi: 10.2174/0115733998291968240429111357.
10
NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.NF-κB/NLRP3 炎性小体轴与 2 型糖尿病帕金森病风险:叙述性综述及新视角。
J Cell Mol Med. 2023 Jul;27(13):1775-1789. doi: 10.1111/jcmm.17784. Epub 2023 May 21.
Neuropharmacology. 2018 Jul 1;136(Pt B):172-181. doi: 10.1016/j.neuropharm.2017.11.027. Epub 2017 Nov 21.
4
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets.将阿尔茨海默病与糖尿病联系起来:潜在机制和潜在治疗靶点。
Neuropharmacology. 2018 Jul 1;136(Pt B):160-171. doi: 10.1016/j.neuropharm.2017.11.014. Epub 2017 Nov 10.
5
Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.二甲双胍降低 MPTP 帕金森病小鼠模型中 α-突触核蛋白的磷酸化并上调神经营养因子。
Neuropharmacology. 2017 Oct;125:396-407. doi: 10.1016/j.neuropharm.2017.08.015. Epub 2017 Aug 12.
6
Guanine glycation repair by DJ-1/Park7 and its bacterial homologs.DJ-1/Park7 及其细菌同源物对鸟嘌呤糖基化的修复。
Science. 2017 Jul 14;357(6347):208-211. doi: 10.1126/science.aag1095. Epub 2017 Jun 8.
7
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.糖基化增强了α-突触核蛋白相关神经退行性变在突触核蛋白病中的作用。
Brain. 2017 May 1;140(5):1399-1419. doi: 10.1093/brain/awx056.
8
Type 2 diabetes.2 型糖尿病。
Lancet. 2017 Jun 3;389(10085):2239-2251. doi: 10.1016/S0140-6736(17)30058-2. Epub 2017 Feb 10.
9
Selective neuronal vulnerability in Parkinson disease.帕金森病中的选择性神经元易损性。
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113. doi: 10.1038/nrn.2016.178.
10
Increased risk of Parkinson disease with diabetes mellitus in a population-based study.一项基于人群的研究:糖尿病增加患帕金森病的风险。
Medicine (Baltimore). 2017 Jan;96(3):e5921. doi: 10.1097/MD.0000000000005921.